HIV infection
Not recruitingStudy on Long-Acting Cabotegravir and Rilpivirine for HIV Patients in Spain: Evaluating Out-of-Hospital Treatment Options
Study on Long-Acting Cabotegravir and Rilpivirine for HIV Patients in Spain: Evaluating Out-of-Hospital Treatment Options
- Disease:HIV infection
- Substances:CabotegravirCabotegravir Sodium+1
Spain- Participants:18–64 years
- Substances:Cabotegravir
- Sponsor:Fundacion Fls De Lucha Contra El Sida Las Enfermedades Infecciosas Y La Promocion De La Salud Y La Ciencia











